Basket | Login | Register

 
 
 
 

EPAD Longitudinal Cohort Study is closed down and EPAD coordinators thank all involved

Wednesday 25 March 2020

On 25 March, Serge Van Der Geyten and Craig Ritchie, the coordinators of the European Prevention of Alzheimer's Dementia (EPAD) project notified the closure of the EPAD Longitudinal Cohort Study to all EPAD members and study team. The grant received by the Innovative Medicines Initiative which has funded EPAD from 2015 runs out in June 2020. The EPAD team worked hard over the past months to guarantee the funding to continue running the Longitudinal Cohort Study from July 2020. Unfortunately, they were not able to secure the necessary resources which resulted in its discontinuation. The project coordinators pointed out that although it will no longer be possible to run the Longitudinal Cohort Study, research into Alzheimer’s disease will continue through the passion and determination of the site staff across Europe. They also highlighted that the collected EPAD data will continue to provide important information and insights about the disease.

The project coordinators thanked all EPAD members and research participants for their commitment to the study and the fight to understand Alzheimer’s disease better. They also took the opportunity to thank friends and family of research participants who supported them in their visits. The news message can be read here: http://ep-ad.org/2020/03/25/message-from-the-epad-coordinators-to-all-involved-in-the-epad-longitudinal-cohort-study/

The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

Options